Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma and prior anti-tumor therapy: A subanalysis from the sharp trial

被引：9
|
作者：
Galle, P. [1 ]
Blanc, J. [2 ]
Van Laethem, J-L. [3 ]
Marrero, J. [4 ]
Beaugrand, M. [5 ]
Moscovici, M. [6 ]
Shan, M. [7 ]
Nadel, A. [7 ]
Voliotis, D. [8 ]
Bruix, J. [9 ]
Llovet, J. M. [9 ,10 ]
机构：
[1] Univ Mainz Klinikum, Mainz, Germany
[2] CHU, Hop St Andre, Bordeaux, France
[3] Erasme Univ Hosp, B-1070 Brussels, Belgium
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] Hop Jean Verdier, Bondy, France
[6] Bayer Schering Pharma, Milan, Italy
[7] Bayer Healthcare Pharmaceut, West Haven, CT USA
[8] Bayer Schering Pharma, Global Clin Dev, Wuppertal, Germany
[9] Hosp Clin Barcelona, Liver Unit, CIBERehd, IDIBAPS,BCLC Grp, Barcelona, Spain
[10] Mt Sinai Sch Med, Div Liver Dis, New York, NY USA
来源：
JOURNAL OF HEPATOLOGY | 2008年 / 48卷
关键词：
D O I：
10.1016/S0168-8278(08)60996-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
994
引用
收藏
页码：S372 / S372
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of sorafenib in patients with advanced HCC and prior anti-tumor therapy: a subanalysis from the SHARP trial
    Galle, P.
    Woerns, M.
    Blanc, J.
    Van Laethem, J.
    Marrero, J.
    Beaugrand, M.
    Moscovici, M.
    Shan, M.
    Nadel, A.
    Voliotis, D.
    Bruix, J.
    Llovet, J.
    ONKOLOGIE, 2010, 33 : 84 - +
  • [2] Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma and vascular invasion or extrahepatic spread: A subanalysis from the SHARP trial
    Sherman, M.
    Mazzaferro, V.
    Amadori, D.
    Seitz, J.
    Moscovici, M.
    Shan, M.
    Nadel, A.
    Voliotis, D.
    Llovet, J. M.
    Bruix, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to ECOG performance status: A subanalysis from the SHARP trial
    Raoul, J.
    Santoro, A.
    Beaugrand, M.
    Marrero, J. A.
    Moscovici, M.
    Shan, M.
    Nadel, A.
    Voliotis, D.
    Bruix, J.
    Llovet, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial
    Rimassa, Lorenza
    Santoro, Armando
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 739 - 745
  • [5] Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET
    S. Negrier
    E. Jäger
    C. Porta
    D. McDermott
    M. Moore
    J. Bellmunt
    S. Anderson
    F. Cihon
    J. Lewis
    B. Escudier
    R. Bukowski
    Medical Oncology, 2010, 27 : 899 - 906
  • [6] Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET
    Negrier, S.
    Jaeger, E.
    Porta, C.
    McDermott, D.
    Moore, M.
    Bellmunt, J.
    Anderson, S.
    Cihon, F.
    Lewis, J.
    Escudier, B.
    Bukowski, R.
    MEDICAL ONCOLOGY, 2010, 27 (03) : 899 - 906
  • [7] Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma
    Cheng, Yang
    Luo, RongCheng
    Zheng, Hang
    Wang, Biao
    Liu, YaHui
    Liu, DingLi
    Chen, JinZhang
    Xu, WanFu
    Li, AiMin
    Zhu, Yun
    ONCOTARGET, 2017, 8 (14) : 23265 - 23276
  • [8] EFFICACY AND SAFETY OF SORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): SUBANALYSIS OF SHARP TRIAL BASED ON BARCELONA CLINIC LIVER CANCER (BCLC) STAGE
    Bruix, J.
    Raoul, J. L.
    Sherman, M.
    Shan, M.
    Lentini, G.
    Nadel, A.
    Voliotis, D.
    Llovet, J. M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S28 - S29
  • [9] Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
    Bruix, Jordi
    Raoul, Jean-Luc
    Sherman, Morris
    Mazzaferro, Vincenzo
    Bolondi, Luigi
    Craxi, Antonio
    Galle, Peter R.
    Santoro, Armando
    Beaugrand, Michel
    Sangiovanni, Angelo
    Porta, Camillo
    Gerken, Guido
    Marrero, Jorge A.
    Nadel, Andrea
    Shan, Michael
    Moscovici, Marius
    Voliotis, Dimitris
    Llovet, Josep M.
    JOURNAL OF HEPATOLOGY, 2012, 57 (04) : 821 - 829
  • [10] Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma
    Marta, Guilherme Nader
    da Fonseca, Leonardo G.
    Braghiroli, Maria Ignez
    Moura, Fernando
    Hoff, Paulo M.
    Sabbaga, Jorge
    CLINICS, 2021, 76 : 1 - 6
12345